| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/12/2008 | CA2661896A1 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin |
| 09/11/2008 | US20080221497 Filter membrane of polypheylacetylene, or cellulosic or chitin polymers modified with arginine, cysteine, or lysine side chains to remove toxic carbonyl compounds; diabetic and uremic dialysis patients |
| 09/11/2008 | US20080221308 HDAC9 polypeptides and polynucleotides and uses thereof |
| 09/11/2008 | US20080221304 Hexapeptide of given formula; binds with opioid receptor and exhibits agonist and antagonist activity; anxiolytics, diuretics, and anti-cancer agents |
| 09/11/2008 | US20080221194 Novel Potassium channel Blockers and Uses Thereof |
| 09/11/2008 | US20080221181 Compounds for treating tumors |
| 09/11/2008 | US20080221156 Stable formulations of ace inhibitors, and methods for preparation thereof |
| 09/11/2008 | US20080221068 Oral administration of an amino acid with a N-terminal blocking group and a N-(2-boric pyrrolyl) group attached to the carboxyl group; anticarcinogenic, antiproliferative, antimetastasis agents for lung, kidney, pancreatic, breast, and colorectal cancers; angiogenesis inhibition |
| 09/11/2008 | US20080221058 Tumor-Specific Vector for Gene Therapy |
| 09/11/2008 | US20080221054 In vitro; transgenic cells, mammals; kits |
| 09/11/2008 | US20080221053 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals; selectively bind coagulation factors, E2F family members, Ang1 or Ang2 |
| 09/11/2008 | US20080221051 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 09/11/2008 | US20080221043 Guanidinium compounds for drug delivery |
| 09/11/2008 | US20080221042 Amyloid precursor proteins; protein kinase C activators |
| 09/11/2008 | US20080221041 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 09/11/2008 | US20080221040 Compositions and Methods for the Control of Mammary Cell Number |
| 09/11/2008 | US20080221039 Kinin Antagonists For Treating Bladder Dysfunction |
| 09/11/2008 | US20080221038 Neuropeptide Y receptor antagonists and agonists including O-glycosylated tripeptides, O-glycopeptides, and extended tripeptides; cardiovascular disorders |
| 09/11/2008 | US20080221037 Methods and compositions for treating disorders involving excitotoxicity |
| 09/11/2008 | US20080221036 Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/11/2008 | US20080221035 For killing Group B streptococci; endopeptidase and muramidase domains |
| 09/11/2008 | US20080221034 Canine specific growth hormone releasing hormone |
| 09/11/2008 | US20080221033 Assaying an inactive natriuretic peptide and an active natriuretic peptide from a patient responsive to cardiac stress;administering a therapeutic agent interfering with the active natriuretic peptide assay but not with the inactive natriuretic peptide assay |
| 09/11/2008 | US20080221032 Proteinaceous construct; an activated factor VII molecule anda 1-4 polysialic acid; controlling bleeding in a mammal during surgery or trauma |
| 09/11/2008 | US20080221031 Kit; an anti-fibrinolytic agent, reducing or preventing perioperative blood loss associated with various ischemias in patients subjected to invasive surgical procedures |
| 09/11/2008 | US20080221030 Inhibition of Wet Type Age Related Macular Degeneration (Amd) by Adiponectin or Acrp 30 |
| 09/11/2008 | US20080221029 Administering a sulfasalazine, a sulfasalazine metabolite, a sulfa-containing compound, a flavone, a flavanone, an isoflavone, a flavanol, a benzoic acid, an indole derivative, a 1,4-Naphthoquinone, a 3-Phenylcoumarin, a 2-phenyl-4-quinoline, a 1-thioflavone, a thioflavin, or a chalcone; lung infections |
| 09/11/2008 | US20080221028 Compositions and Methods for Treating Atherosclerosis |
| 09/11/2008 | US20080221027 Administrating a composition to artificially increase sarcospan activity in a muscle tissue of the patient; increasing the dystrophin-related complex |
| 09/11/2008 | US20080221026 Fermentation; producing NAP in a suitable host, integrating a sequence encoding NAP into the genome of the host; a recovery process of separating NAP from cells and cellular debris; purification |
| 09/11/2008 | US20080221025 Use of Trpc Channel for the Treatment of a Cardiovascular Disease |
| 09/11/2008 | US20080221024 ShK toxin attached to an atom, molecule, group, residue, compound, moiety that has an anionic charge; multiple sclerosis, type-1 diabetes mellitus, rheumatoid arthritis and psoriasis |
| 09/11/2008 | US20080221023 Administering protein hydrolysates; dipeptidyl peptidase IV diseases; obesity, type II diabetes mellitus, autoimmune diseases |
| 09/11/2008 | US20080221022 Administering prouroguanylin and a diuretic; kidney disease, heart disease, liver disease, hypertension |
| 09/11/2008 | US20080221021 Novel Corticotropin-Releasing Factor Receptor 1 (Crfr1) Agonist |
| 09/11/2008 | US20080221020 Dendrimers as Molecular Translocators |
| 09/11/2008 | US20080221019 Treatment of Inclusion Body Myositis |
| 09/11/2008 | US20080221018 Crystalline solid and amorphous forms of (-)- halofenate and methods related thereto |
| 09/11/2008 | US20080221017 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration |
| 09/11/2008 | US20080221016 Modulating Glucocorticoid Induced TNF Receptor with an agent that binds GITR; binding a fusion protein to a GITR ligand to modulate regulatory T cell function; Multiple Sclerosis, Insulin-Dependent Diabetes Mellitus, Inflammatory Bowel Disease, Ulcerative Colitis, Crohns Disease |
| 09/11/2008 | US20080221015 Isolated peptide; a variant, derivative or structural equivalent of a cupredoxin binding to an ephrin receptor; anticarcinogen |
| 09/11/2008 | US20080221014 Method of Diagnosing and Treating Glioma |
| 09/11/2008 | US20080221013 administering a lynx1, lynx2, or lynx 3 polypeptide or nucleic acid; neurological disorder. |
| 09/11/2008 | US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 09/11/2008 | US20080221011 CR2-FH C-reactive protein, factor H fusion protein; inhibiting complement activation of the alternative pathway |
| 09/11/2008 | US20080220506 Device comprising biopolymer gel dispersion feed pump for preparing solid support for cell propagation |
| 09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
| 09/11/2008 | US20080220470 Protein hydrolysate rich in tripeptides |
| 09/11/2008 | US20080220425 Isothermal amplification of a synthetic DNA from a target nucleic acid, forming a nucleic acid invasive cleavage structure on the synthetic DNA, and detecting cleavage of the nucleic acid invasive cleavage structure as an indicator of the preset of the target nucleic acid |
| 09/11/2008 | US20080220406 Physiologically acceptable aqueous solutions and methods for their use |
| 09/11/2008 | US20080220098 Formulations of alpha-amylase inhibitors with alpha-glucosidase innhibitors useful in the treatment of diabetes and obesity |
| 09/11/2008 | US20080220097 Taken before meals, reduces the appetite, leading to a reduction in body weight |
| 09/11/2008 | US20080220095 Red blood cells loaded with s-nitrosothiol and uses therefor |
| 09/11/2008 | US20080220093 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 09/11/2008 | US20080220079 Sustained release spherical or non-spherical pellets comprising (a) an active ingredient (b) a wax-like agent, and (c) a spheronizing agent; oral dosage forms; drug such as antivirals, vitamins, NSAIDS, antibiotics, insect growth regulators; dosing flexibility e.g. for animals |
| 09/11/2008 | US20080220073 The Treatment of Respiratory Diseases |
| 09/11/2008 | US20080220070 Controlled release system and manufacturing method thereof |
| 09/11/2008 | US20080220056 Treatment for liver disease |
| 09/11/2008 | US20080220053 Process for the Preparation of Two and Three Dimensional Polymer Scaffolds |
| 09/11/2008 | US20080220052 administering polylysine to mammals as dietetics |
| 09/11/2008 | US20080220049 Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins |
| 09/11/2008 | US20080220047 Low-swelling biocompatible hydrogels |
| 09/11/2008 | US20080220043 Providing an osteogenic protein in a biocompatible bioresorbable carrier to defect locus, thereby inducing formation of functional replacement cartilage tissue; medical device for repairing a defect in an intervertebral disc |
| 09/11/2008 | US20080220042 Biomolecule-linked biomimetic scaffolds |
| 09/11/2008 | US20080220025 grafting a mixture of alloactivated lymphocytes in a compatible drug excipient, in or around a tumor site, to elicite an antitumor immunology response; cellular immunology and cancer therapy |
| 09/11/2008 | US20080220020 Transdermal Botulinum Toxin Compositions |
| 09/11/2008 | US20080220013 Diagnostic Method for Brain Damage-Related Disorders |
| 09/11/2008 | US20080220007 Ehrlichia canis genes and vaccines |
| 09/11/2008 | US20080220004 Administering fusion proteins, immunoglobulins, and multimeric proteins; pharmacokinetics; age-related macular degeneration and diabetic retinopathy |
| 09/11/2008 | US20080220003 C5a Receptor Antagonists |
| 09/11/2008 | US20080220002 Modified transferin-antibody fusion proteins |
| 09/11/2008 | US20080219999 Immunoadhesin for the prevention of rhinovirus infection |
| 09/11/2008 | US20080219998 Anticoagulant for use in treatment and prevention of thrombosis or thrombin-dependent vaso-occlusive disease; selective reduction of intravascular thromboplastin antecedent activity |
| 09/11/2008 | US20080219997 Her-2 binding antagonists |
| 09/11/2008 | US20080219994 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 09/11/2008 | US20080219992 Pancreatic protein for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219987 Amino acid sequences associated with cell cycle regulating proteins (CDC25b) for use as immunoglobulin targets in treatment of breast and pancreatic tumors; immunotherapy |
| 09/11/2008 | US20080219986 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 09/11/2008 | US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 09/11/2008 | US20080219983 Antihemophilic factor specific peptides for use as therapeutic tools in treatment of blood disorders |
| 09/11/2008 | US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219976 Methods and compositions for treatment and prevention of staphylococcal infections |
| 09/11/2008 | US20080219973 Using antigalectin-3 immunoglobulin as therapeutic in prevention and treatment of glomerulonephritis, diabetic nephropathy and/or tissue fibrosis |
| 09/11/2008 | US20080219972 Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer |
| 09/11/2008 | US20080219968 Son of sevenless homolog 1 (SOS1) suppressive agent for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219967 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 09/11/2008 | US20080219966 Viewing attention deficit disorder as protein degradation defect and treat via trypsin, protease, chymotrypsin and/or pancreatic enzyme digestion |
| 09/11/2008 | US20080219965 Phytase Variants |
| 09/11/2008 | US20080219964 Methods and products for enhancing energy and nutrition in human beings |
| 09/11/2008 | US20080219962 Method to Enhance the Bone Formation Activity of Bmp by Runx2 Acetylation |
| 09/11/2008 | US20080219954 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells |
| 09/11/2008 | US20080219952 culturing a human interferon producing cells in a serum-free medium, comprising hydroxyethyl piperazinyl ethanesulfonic acid(HEPES), proline sodium chloride and phenol red; drugs used for treating multiple sclerosis, viral diseases or cancer |
| 09/11/2008 | US20080219951 Fluid mixture for enhancing implantable drug delivery at body temperature |
| 09/11/2008 | US20080219950 Derivatives of growth hormone and related proteins |
| 09/11/2008 | US20080219949 Methods for treating brain cancer using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 09/11/2008 | US20080219948 Angiogenesis inhibitors; immunomodulators; side effect reduction |